Celltrion

Celltrion, Inc.
TypePublic
KRX: 068270
IndustryBiopharmaceutical
Founded2002 (2002)
FounderSeo Jung-jin
HeadquartersYeonsu-gu, Incheon, South Korea
Area served
Worldwide
Key peopleSeo Jung-jin, Chairman
Kee Woo-sung, CEO
ProductsRemsima™, Truxima™, Herzuma™, Biosimilar Drug
RevenueIncrease ₩4,162,500 million (2025)
Increase ₩1,168,500 million (2025)
Increase ₩1,031,500 million (2025)
Total assetsIncrease ₩22,334,900 million (2025)
Total equityIncrease ₩17,352,500 million (2025)
OwnerCelltrion Holdings Co., Ltd. (23.03%)
Ion Investments B.V. (9.54%)
National Pension Service (6.07%)
Number of employees
2,995 (2025)
SubsidiariesCelltrion Entertainment
Websitewww.celltrion.com/en

Celltrion, Inc. (Korean: 주식회사 셀트리온) is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year.